McDonald M, Kaufman H, Frantz J, Shofner S, Salmeron B, Klyce S. Excimer laser ablation in a human eye. Case report. Arch. Ophthalmol. 107(5), 641-642 (1989).
Seiler T, Bende T, Wollensak J, Trokel S. Excimer laser keratectomy for correction of astigmatism. Am. J. Ophthalmol. 105(2), 117-124 (1988).
Yu E, Jackson W. Recet advances in refractive surgery. CMAJ 160, 1329-1337 (1999).
Jackson W, Casson E, Hodge W, Mintsioulis G, Agapitos P. Laser vision correction for low hyperopia: an 18-month assessment of safety and efficacy. Ophthalmology 105, 1727-1738 (1998).
Vinviguerra P, Epstein D, Radice P, Azzolini M. Long-term results of photorefractive keratectomy for hyperopia and hyperopic astigmatism. J. Refract. Surg. 14(2 Suppl.), S183-S185 (1998).
Seiler T. Excimer laser photorefractive keratectomy. Surveys Ophthalmol. 40, 89-118 (1995).
Flowers CJ, McDonnell P, McLeod S. Excimer laser photorefractive keratectomy. Ophthalmol. Clin. North Am. 14(2), 275-283 (2001).
Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J. Cataract. Refract. Surg. 28(12), 2088-2095 (2002).
Majmudar P, Forstot S, Dennis R et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 107(1), 89-94 (2000).
Kim TI, Pak JH, Lee SY, Tchah H. Mitomycin C-induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 45(9), 2978-2984 (2004).
Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J. Refract. Surg. 22(6), 562-574 (2006).
Rajan MS, O'Brart DP, Patmore A, Marshall J. Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy. J. Cataract Refract. Surg. 32(10), 1741-1747 (2006).
Morales AJ, Zadok D, Mora-Retana R, Martinez-Gama E, Robledo NE, Chayet AS. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am. J. Ophthalmol. 142(3), 400-404 (2006).
Nassiri N, Farahangiz S, Rahnavardi M, Rahmani L. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J. Cataract Refract. Surg. 34(6), 902-908 (2008).
Teus MA, de Benito-Llopis L, Alio JL. Mitomycin C in corneal refractive surgery. Surv. Ophthalmol. 54(4), 487-502 (2009).
Hersh P, Stulting R, Steinert R et al. Results of Phase III excimer laser photorefractive keratectomy for myopia. The Summit PRK Study Group. Ophthalmology 104(10), 1535-1553 (1997).
Pallikaris I, Papatzanaki M, Stathi E, Frenschock O, Georgiadis A. Laser in situ keratomileusis. Lasers Surg. Med. 10(5), 463-468 (1990).
Carr J, Stulting R, Thompson K, Waring GI. Laser in situ keratomileusis surgical technique. Ophthalmol. Clin. North Am. 14(2), 285-294 (2001).
Shortt AJ, Bunce C, Allan BD. Evidence for superior efficacy and safety of LASIK over photorefractive keratectomy for correction of myopia. Ophthalmology 113(11), 1897-1908 (2006).
Shortt AJ, Allan BD. Photorefractive keratectomy (PRK) versus laser-assisted in-situ keratomileusis (LASIK) for myopia. Cochrane Database Syst. Rev. 2, CD005135 (2006).
Hersh PS, Brint SF, Maloney RK et al. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study. Ophthalmology 105(8), 1512-1522; discussion 1522-1523 (1998).
Hersh PS, Steinert RF, Brint SF. Photorefractive keratectomy versus laser in situ keratomileusis: comparison of optical side effects. Summit PRK-LASIK Study Group. Ophthalmology 107(5), 925-933 (2000).
Neeracher B, Senn P, Schipper I. Glare sensitivity and optical side effects 1 year after photorefractive keratectomy and laser in situ keratomileusis. J. Cataract Refract. Surg. 30(8), 1696-1701 (2004).
Yang XJ, Yan HT, Nakahori Y. Evaluation of the effectiveness of laser in situ keratomileusis and photorefractive keratectomy for myopia: a meta-analysis. J. Med. Invest. 50(3-4), 180-186 (2003).
Pirouzian A, Thornton J, Ngo S. One-year outcomes of a bilateral randomized prospective clinical trial comparing laser subepithelial keratomileusis and photorefractive keratectomy. J. Refract. Surg. 22(6), 575-579 (2006).
Slade SG. Thin-flap laser-assisted in situ keratomileusis. Curr. Opin. Ophthalmol. 19(4), 325-329 (2008).
Wilson SE. LASIK: management of common complications. Laser in situ keratomileusis. Cornea 17(5), 459-467 (1998).
Gimbel HV, Penno EE, van Westenbrugge JA, Ferensowicz M, Furlong MT. Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis cases. Ophthalmology 105(10), 1839-1847; discussion 1847-1848 (1998).
Knorz MC. Flap and interface complications in LASIK. Curr. Opin. Ophthalmol. 13(4), 242-245 (2002).
Steinert RF, Bafna S. Surgical correction of moderate myopia: which method should you choose? II. PRK and LASIK are the treatments of choice. Surv. Ophthalmol. 43(2), 157-179 (1998).
Smith RJ, Maloney RK. Diffuse lamellar keratitis. A new syndrome in lamellar refractive surgery. Ophthalmology 105(9), 1721-1726 (1998).
Slade SG. The use of the femtosecond laser in the customization of corneal flaps in laser in situ keratomileusis. Curr. Opin. Ophthalmol. 18(4), 314-317 (2007).
Buzzonetti L, Petrocelli G, Valente P et al. Comparison of corneal aberration changes after laser in situ keratomileusis performed with mechanical microkeratome and IntraLase femtosecond laser: 1-year follow-up. Cornea 27(2), 174-179 (2008).
Durrie DS, Kezirian GM. Femtosecond laser versus mechanical keratome flaps in wavefront-guided laser in situ keratomileusis: prospective contralateral eye study. J. Cataract Refract. Surg. 31(1), 120-126 (2005).
Tran DB, Sarayba MA, Bor Z et al. Randomized prospective clinical study comparing induced aberrations with IntraLase and Hansatome flap creation in fellow eyes: potential impact on wavefront-guided laser in situ keratomileusis. J. Cataract Refract. Surg. 31(1), 97-105 (2005) .
Salomao MQ, Ambrosio R Jr, Wilson SE. Dry eye associated with laser in situ keratomileusis: mechanical microkeratome versus femtosecond laser. J. Cataract Refract. Surg. 35(10), 1756-1760 (2009).
Stahl JE, Durrie DS, Schwendeman FJ, Boghossian AJ. Anterior segment OCT analysis of thin IntraLase femtosecond flaps. J. Refract. Surg. 23(6), 555-558 (2007).
Kim JH, Lee D, Rhee KI. Flap thickness reproducibility in laser in situ keratomileusis with a femtosecond laser: optical coherence tomography measurement. J. Cataract Refract. Surg. 34(1), 132-136 (2008).
Shemesh G, Dotan G, Lipshitz I. Predictability of corneal flap thickness in laser in situ keratomileusis using three different microkeratomes. J. Refract. Surg. 18(3 Suppl.), S347-S351 (2002).
Knorz MC, Vossmerbaeumer U. Comparison of flap adhesion strength using the Amadeus microkeratome and the IntraLase iFS femtosecond laser in rabbits. J. Refract. Surg. 24(9), 875-878 (2008).
Kezirian GM, Stonecipher KG. Comparison of the IntraLase femtosecond laser and mechanical keratomes for laser in situ keratomileusis. J. Cataract Refract. Surg. 30(4), 804-811 (2004).
Kim JY, Kim MJ, Kim TI, Choi HJ, Pak JH, Tchah H. A femtosecond laser creates a stronger flap than a mechanical microkeratome. Invest. Ophthalmol. Vis. Sci. 47(2), 599-604 (2006).
Nordan LT, Slade SG, Baker RN, Suarez C, Juhasz T, Kurtz R. Femtosecond laser flap creation for laser in situ keratomileusis: six-month follow-up of initial U.S. clinical series. J. Refract. Surg. 19(1), 8-14 (2003).
Binder PS. One thousand consecutive IntraLase laser in situ keratomileusis flaps. J. Cataract Refract. Surg. 32(6), 962-969 (2006) .
Stonecipher K, Ignacio TS, Stonecipher M. Advances in refractive surgery: microkeratome and femtosecond laser flap creation in relation to safety, efficacy, predictability, and biomechanical stability. Curr. Opin. Ophthalmol. 17(4), 368-372 (2006).
Soong HK, Malta JB. Femtosecond lasers in ophthalmology. Am. J. Ophthalmol. 147(2), 189-197.e2 (2009).
Durrie DS, Slade SG, Marshall J. Wavefront-guided excimer laser ablation using photorefractive keratectomy and sub-Bowman's keratomileusis: a contralateral eye study. J. Refract. Surg. 24(Suppl. 1), S77-S84 (2008).
Javaloy J, Vidal MT, Abdelrahman AM, Artola A, Alio JL. Confocal microscopy comparison of intralase femtosecond laser and Moria M2 microkeratome in LASIK. J. Refract. Surg. 23(2), 178-187 (2007).
Rocha KM, Kagan R, Smith SD, Krueger RR. Thresholds for interface haze formation after thin-flap femtosecond laser in situ keratomileusis for myopia. Am. J. Ophthalmol. 147(6), 966-972, 972.e1 (2009).
Chang JS. Complications of sub-Bowman's keratomileusis with a femtosecond laser in 3009 eyes. J. Refract. Surg. 24(1), S97-S101 (2008).
Netto MV, Mohan RR, Medeiros FW et al. Femtosecond laser and microkeratome corneal flaps: comparison of stromal wound healing and inflammation. J. Refract. Surg. 23(7), 667-676 (2007).
Stonecipher KG, Dishler JG, Ignacio TS, Binder PS. Transient light sensitivity after femtosecond laser flap creation: clinical findings and management. J. Cataract Refract. Surg. 32(1), 91-94 (2006).
Scerrati E. Laser in situ keratomileusis vs. laser epithelial keratomileusis (LASIK vs. LASEK). J. Refract. Surg. 17(2 Suppl.), S219-S221 (2001).
Kornilovsky IM. Clinical results after subepithelial photorefractive keratectomy (LASEK). J. Refract. Surg. 17(2 Suppl.), S222-S223 (2001).
Panagopoulou SI, Pallikaris IG. Wavefront customized ablations with the WASCA Asclepion workstation. J. Refract. Surg. 17(5), S608-S612 (2001).
Azar DT, Ang RT, Lee JB et al. Laser subepithelial keratomileusis: electron microscopy and visual outcomes of flap photorefractive keratectomy. Curr. Opin. Ophthalmol. 12(4), 323-328 (2001).
Cimberle U, Camellin M. LASEK may offer the advantages of both LASIK and PRK. Ocular Surg. News Inter. 10, 14-15 (1999).
Pallikaris IG, Katsanevaki VJ, Kalyvianaki MI, Naoumidi II. Advances in subepithelial excimer refractive surgery techniques: Epi-LASIK. Curr. Opin. Ophthalmol. 14(4), 207-212 (2003).
Anderson NJ, Beran RF, Schneider TL. Epi-LASEK for the correction of myopia and myopic astigmatism. J. Cataract Refract. Surg. 28(8), 1343-1357 (2002).
Claringbold TV 2nd. Laser-assisted subepithelial keratectomy for the correction of myopia. J. Cataract Refract. Surg. 28(1), 18-22 (2002).
Shahinian L Jr. Laser-assisted subepithelial keratectomy for low to high myopia and astigmatism. J. Cataract Refract. Surg. 28(8), 1334-1342 (2002).
Azar DT, Ang RT. Laser subepithelial keratomileusis: evolution of alcohol assisted flap surface ablation. Int. Ophthalmol. Clin. 42(4), 89-97 (2002).
Litwak S, Zadok D, Garcia-de Quevedo V, Robledo N, Chayet AS. Laser-assisted subepithelial keratectomy versus photorefractive keratectomy for the correction of myopia. A prospective comparative study. J. Cataract Refract. Surg. 28(8), 1330-1333 (2002).
Camellin M, Cimberle U. LASEK technique promising after 1 year of experience. Ocular Surgery News 18, 14-17 (2000) .
Lee JB, Choe CM, Seong GJ, Gong HY, Kim EK. Laser subepithelial keratomileusis for low to moderate myopia: 6-month follow-up. Jpn J. Ophthalmol. 46(3), 299-304 (2002).
Lee JB, Seong GJ, Lee JH, Seo KY, Lee YG, Kim EK. Comparison of laser epithelial keratomileusis and photorefractive keratectomy for low to moderate myopia. J. Cataract Refract. Surg. 27(4), 565 -570 (2001) .
Lee JB, Choe CM, Kim HS, Seo KY, Seong GJ, Kim EK. Comparison of TGF-p1 in tears following laser subepithelial keratomileusis and photorefractive keratectomy. J. Refract. Surg. 18 (2), 130 -134 (2002).
Shah S, Sebai Sarhan AR, Doyle SJ, Pillai CT, Dua HS. The epithelial flap for photorefractive keratectomy. Br. J. Ophthalmol. 85(4), 393-396 (2001).
Pirouzian A, Thornton JA, Ngo S. A randomized prospective clinical trial comparing laser subepithelial keratomileusis and photorefractive keratectomy. Arch. Ophthalmol. 122(1), 11-16 (2004).
Feit R, Taneri S, Azar DT, Chen CC, Ang RT. LASEK results. Ophthalmol. Clin. North Am. 16(1), 127-135, viii (2003).
Ayres BD, Rapuano CJ. Excimer laser phototherapeutic keratectomy. Ocul. Surf. 4(4), 196-206 (2006).
Stasi K, Chuck RS. Update on phototherapeutic keratectomy. Curr. Opin. Ophthalmol. 20(4), 272-275 (2009).
Rapuano CJ. Phototherapeutic keratectomy: who are the best candidates and how do you treat them? Curr. Opin. Ophthalmol. 21(4), 280-282 (2010).
Stark W, Chamon W, Kamp M, Enger C, Rencs E, Gottsh J. Clinical follow-up of 193-nm ArF excimer laser photokeratectomy. Ophthalmology 99(5), 805-812 (1992).
Rapuano C. Excimer laser phototherapeutic keratectomy: long-term results and practical considerations. Cornea 16(2), 151-157 (1997).
Marcon A, Rapuano C. Excimer laser phototherapeutic keratectomy retreatment of anterior basement membrane dystrophy and Salzmann's nodular degeneration with topical mitomycin C. Cornea 21(8), 828-830 (2002).
Das S, Langenbucher A, Seitz B. Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: a comparative study. J. Refract. Surg. 21(6), 727-731 (2005).
Fasano P, Moreira H, McDonnel P, Sinbawy A. Excimer laser smoothing with a reproducible model of anterior corneal surface irregularity. Ophthalmology 98, 1782-1785 (1991).
Alio JL, Belda JI, Shalaby AM. Correction of irregular astigmatism with excimer laser assisted by sodium hyaluronate. Ophthalmology 108(7), 1246-1260 (2001).
Hersh PS, Spinak A, Garrana R, Mayers M. Phototherapeutic keratectomy: strategies and results in 12 eyes. Refract. Corneal Surg. 9(Suppl. 2), S90-S95 (1993).
Stevens S, Bowyer B, Sanchez-Thorin J, Rocha G, Young D, Rowsey J. The BioMask for treatment of corneal surface irregularities with excimer laser phototherapeutic keratectomy. Cornea 18(2), 155-163 (1999).
Kremer F, Aronsky M, Bowyer B, Stevens SX. Treatment of corneal surface irregularities using biomask as an adjunct to excimer laser phototherapeutic keratectomy. Cornea 21(1), 28-32 (2002).
Pallikaris I, Katsanevaki V, Ginis H. The PALM technique as an alternative to customized ablation. Semin. Ophthalmol. 15, 160-169 (2000).
Stevens SX, Bowyer BL. Corneal modulators and their use in excimer laser phototherapeutic keratectomy. Int. Ophthalmol. Clin. 36(4), 119-125 (1996).
El Danasoury AM, Bains HS. Customized aspheric treatment zone ablation to treat irregular corneas after corneal refractive surgery. J. Refract. Surg. 25(10 Suppl.), S917-S921 (2009).
Alio J, Galal A, Montalban R, Pinero D. Corneal wavefront-guided LASIK retreatments for correction of highly aberrated corneas following refractive surgery. J. Refract. Surg. 23(8), 760-773 (2007).
Baryla J, Pan YI, Hodge WG. Long-term< efficacy of phototherapeutic keratectomy on recurrent corneal erosion syndrome. Cornea 25(10), 1150-1152 (2006).
Lie J, Droutsas K, Ham L et al. Isolated Bowman layer transplantation to manage persistent subepithelial haze after excimer laser surface ablation. J. Cataract Refract. Surg. 36(6), 1036-1041 (2010).
Polack FM. Lamellar keratoplasty. Malbran's 'peeling off' technique. Arch. Ophthalmol. 86(3), 293-295 (1971).
Price F W Jr. Air lamellar keratoplasty. Refract. Corneal Surg. 5(4), 240-243 (1989).
Alio JL, Shah S, Barraquer C, Bilgihan K, Anwar M, Melles GR. New techniques in lamellar keratoplasty. Curr. Opin. Ophthalmol. 13(4), 224-229 (2002).
Jimenez-Alfaro I, Perez-Santonja JJ, Gomez Telleria G, Bueno Palacin JL, Puy P. Therapeutic lamellar keratoplasty with an automated microkeratome. J. Cataract Refract. Surg. 27(8), 1161-1165 (2001).
Jain S, Azar DT. New lamellar keratoplasty techniques: posterior keratoplasty and deep lamellar keratoplasty. Curr. Opin. Ophthalmol. 12(4), 262-268 (2001).
Sugita J, Kondo J. Deep lamellar keratoplasty with complete removal of pathological stroma for vision improvement. Br. J. Ophthalmol. 81(3), 184-188 (1997).
Melles GR, Lander F, van Dooren BT, Pels E, Beekhuis WH. Preliminary clinical results of posterior lamellar keratoplasty through a sclerocorneal pocket incision. Ophthalmology 107(10), 1850-1856; discussion 1857 (2000).
Manche EE, Holland GN, Maloney RK. Deep lamellar keratoplasty using viscoelastic dissection. Arch. Ophthalmol. 117(11), 1561-1565 (1999).
Melles GR, Remeijer L, Geerards AJ, Beekhuis WH. A quick surgical technique for deep, anterior lamellar keratoplasty using visco-dissection. Cornea 19 (4), 427-432 (2000).
Melles GR, Lander F, Rietveld FJ, Remeijer L, Beekhuis WH, Binder PS. A new surgical technique for deep stromal, anterior lamellar keratoplasty. Br. J. Ophthalmol. 83(3), 327-333 (1999).
Melles GR, Lander F, Beekhuis WH, Remeijer L, Binder PS. Posterior lamellar keratoplasty for a case of pseudophakic bullous keratopathy. Am. J. Ophthalmol. 127(3), 340-341 (1999).
Archila EA. Deep lamellar keratoplasty dissection of host tissue with intrastromal air injection. Cornea 3(3), 217-218 (1984).
Morris E, Kirwan JF, Sujatha S, Rostron CK. Corneal endothelial specular microscopy following deep lamellar keratoplasty with lyophilised tissue. Eye (Lond.) 12(Pt 4), 619-622 (1998).
Chau GK, Dilly SA, Sheard CE, Rostron CK. Deep lamellar keratoplasty on air with lyophilised tissue. Br. J. Ophthalmol. 76(11), 646-650 (1992).
Anwar M, Teichmann KD. Deep lamellar keratoplasty: surgical techniques for anterior lamellar keratoplasty with and without baring of Descemet's membrane. Cornea 21(4), 374-383 (2002).
Anwar M, Teichmann KD. Big-bubble technique to bare Descemet's membrane in anterior lamellar keratoplasty. J. Cataract Refract. Surg. 28(3), 398-403 (2002).
Azar DT, Jain S, Sambursky R. A new surgical technique of microkeratome-assisted deep lamellar keratoplasty with a hinged flap. Arch. Ophthalmol. 118(8), 1112-1115 (2000).
Ardjomand N, Hau S, McAlister JC et al. Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am. J. Ophthalmol. 143(2), 228-235 (2007).
Han DC, Mehta JS, Por YM, Htoon HM, Tan DT. Comparison of outcomes of lamellar keratoplasty and penetrating keratoplasty in keratoconus. Am. J. Ophthalmol. 148(5), 744-751.e1 (2009).
Fontana L, Parente G, Tassinari G. Clinical outcomes after deep anterior lamellar keratoplasty using the big-bubble technique in patients with keratoconus. Am. J. Ophthalmol. 143(1), 117-124 (2007).
Sarnicola V, Toro P, Gentile D, Hannush SB. Descemetic DALK, predescemetic DALK: outcomes in 236 cases of keratoconus. Cornea 29(1), 53-59 (2009).
Fogla R, Padmanabhan P. Results of deep lamellar keratoplasty using the big-bubble technique in patients with keratoconus. Am. J. Ophthalmol. 141(2), 254-259 (2006).
Watson SL, Ramsay A, Dart JK, Bunce C, Craig E. Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus. Ophthalmology 111(9), 1676-1682 (2004).
Leccisotti A. Air-assisted manual deep anterior lamellar keratoplasty for treatment of herpetic corneal scars. Cornea 28(7), 728-731 (2009).
Funnell CL, Ball J, Noble BA. Comparative cohort study of the outcomes of deep lamellar keratoplasty and penetrating keratoplasty for keratoconus. Eye (Lond.) 20(5), 527-532 (2006).
Al-Torbak AA, Al-Motowa S, Al-Assiri A et al. Deep anterior lamellar keratoplasty for keratoconus. Cornea 25 (4), 408-412 (2006). 115 Noble BA, Agrawal A, Collins C, Saldana
Farid M, Steinert RF. Deep anterior lamellar keratoplasty performed with the femtosecond laser zigzag incision for the treatment of stromal corneal pathology and ectatic disease. J. Cataract Refract. Surg. 35(5), 809-813 (2009).
Price FW Jr, Price MO, Grandin JC, Kwon R. Deep anterior lamellar keratoplasty with femtosecond-laser zigzag incisions. J. Cataract Refract. Surg. 35(5), 804-808 (2009).
Torquetti L, Berbel RF, Ferrara P. Long-term follow-up of intrastromal corneal ring segments in keratoconus. J. Cataract Refract. Surg. 35(10), 1768-1773 (2009).
Pinero DP, Alio JL, Uceda-Montanes A, El Kady B, Pascual I. Intracorneal ring segment implantation in corneas with post-laser in situ keratomileusis keratectasia. Ophthalmology 116(9), 1665-1674 (2009).
Krueger RR, Burris TE. Intrastromal corneal ring technology. Int. Ophthalmol. Clin. 36(4), 89-106 (1996).
Tham VM, Hwang DG. The intrastromal corneal ring segments: Intacs. Ophthalmol. Clin. North Am. 14(2), 295-299, viii (2001).
Colin J, Cochener B, Savary G, Malet F. Correcting keratoconus with intracorneal rings. J. Cataract Refract. Surg. 26(8), 1117-1122 (2000).
Shetty R, Kurian M, Anand D, Mhaske P, Narayana KM, Shetty BK. Intacs in advanced keratoconus. Cornea 27(9), 1022-1029 (2008).
Shabayek MH, Alio JL. Intrastromal corneal ring segment implantation by femtosecond laser for keratoconus correction. Ophthalmology 114(9),< 1643-1652 (2007).
Ertan A, Ozkilic E. Effect of age on outcomes in patients with keratoconus treated by Intacs using a femtosecond laser. J. Refract. Surg. 24(7), 690-695 (2008).
Alio JL, Shabayek MH, Belda JI, Correas P, Feijoo ED. Analysis of results related to good and bad outcomes of Intacs implantation for keratoconus correction. J. Cataract Refract. Surg. 32(5), 756-761 (2006).
Carrasquillo KG, Rand J, Talamo JH. Intacs for keratoconus and post-LASIK ectasia: mechanical versus femtosecond laser-assisted channel creation. Cornea 26(8), 956-962 (2007).
Ferrara de A, Cunha P. [Surgical techniques for correction of myopia: intrastromal corneal ring]. Rev. Bras. Oftalmol. 54, 577-588 (1995).
Mularoni A, Torreggiani A, di Biase A, Laffi GL, Tassinari G. Conservative treatment of early and moderate pellucid marginal degeneration: a new refractive approach with intracorneal rings. Ophthalmology 112(4), 660-666 (2005).
Ertan A, Bahadir M. Management of superior pellucid marginal degeneration with a single intracorneal ring segment using femtosecond laser. J. Refract. Surg. 23(2), 205-208 (2007).
Ertan A, Bahadir M. Intrastromal ring segment insertion using a femtosecond laser to correct pellucid marginal corneal degeneration. J. Cataract Refract. Surg. 32(10), 1710-1716 (2006).
Kymionis GD, Tsiklis NS, Pallikaris AI et al. Long-term follow-up of Intacs for post-LASIK corneal ectasia. Ophthalmology 113(11), 1909-1917 (2006).
Uceda-Montanes A, Tomas JD, Alio JL. Correction of severe ectasia after LASIK with intracorneal ring segments. J. Refract. Surg. 24(4), 408-411 (2008).
Sporl E, Huhle M, Kasper M, Seiler T. [Increased rigidity of the cornea caused by intrastromal cross-linking]. Ophthalmologe 94(12), 902-906 (1997).
Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp. Eye Res. 66(1), 97-103 (1998).
Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J. Cataract Refract. Surg. 33(12), 2035-2040 (2007).
Mazzotta C, Traversi C, Baiocchi S, Sergio P, Caporossi T, Caporossi A. Conservative treatment of keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: qualitative investigation. Eur. J. Ophthalmol. 16(4), 530-535 (2006).
Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J. Cataract Refract. Surg. 32(5), 837-845 (2006).
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am. J. Ophthalmol. 135 (5), 620-627 (2003).
Kohlhaas M, Spoerl E, Speck A, Schilde T, Sandner D, Pillunat LE. [A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking]. Klin. Monbl. Augenheilkd. 222(5), 430-436 (2005).
Hafezi F, Mrochen M, Iseli HP, Seiler T. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J. Cataract Refract. Surg. 35(4), 621-624 (2009).
Spoerl E, Wollensak G, Dittert DD, Seiler T. Thermomechanical behavior of collagen-cross-linked porcine cornea. Ophthalmologica 218(2), 136-140 (2004).
Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea 23(5), 503-507 (2004).
Jankov Ii MR, Jovanovic V, Nikolic L, Lake JC, Kymionis G, Coskunseven E. Corneal collagen cross-linking. Middle East Afr. J. Ophthalmol. 17(1), 21-27 (2010).
Samaras KE, Lake DB. Corneal collagen cross linking (CXL): a review. Int. Ophthalmol. Clin. 50(3), 89-100 (2010).
Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 29(1), 35-40 (2004).
Meek KM, Tuft SJ, Huang Y et al. Changes in collagen orientation and distribution in keratoconus corneas. Invest. Ophthalmol. Vis. Sci. 46(6), 1948-1956 (2005).
Vinciguerra P, Albe E, Trazza S et al. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology 116(3), 369-378 (2009).
Coskunseven E, Jankov MR 2nd, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus. J. Refract. Surg. 25(4), 371-376 (2009).
Wittig-Silva C, Whiting M, Lamoureux E, Lindsay RG, Sullivan LJ, Snibson GR. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J. Refract. Surg. 24(7), S720-S725 (2008).
Vinciguerra P, Camesasca FI, Albe E, Trazza S. Corneal collagen cross-linking for ectasia after excimer laser refractive surgery: 1-year results. J. Refract. Surg. 22, 1-12 (2009).
Krueger RR, Ramos-Esteban JC, Kanellopoulos AJ. Staged intrastromal delivery of riboflavin with UVA cross-linking in advanced bullous keratopathy: laboratory investigation and first clinical case. J. Refract. Surg. 24(7), S730-S736 (2008).
Wollensak G, Aurich H, Wirbelauer C, Pham DT. Potential use of riboflavin-UVA cross-linking in bullous keratopathy. Ophthalmic Res. 41(2), 114-117 (2009).
Ehlers N, Hjortdal J, Nielsen K, Sondergaard A. Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea. J. Refract. Surg. 25(9), S803-S806 (2009).
Bottos KM, Hofling-Lima AL, Barbosa MC et al. Effect of collagen cross-linking in stromal fibril organization in edematous human corneas. Cornea 29(7), 789-793 (2010).
Cordeiro Barbosa MM, Barbosa JB Jr, Hirai FE, Hofling-Lima AL. Effect of cross-linking on corneal thickness in patients with corneal edema. Cornea 29 (6), 613-617 (2010).
Hayes S, Kamma-Lorger CS. Corneal collagen cross-linking in bullous keratopathy. J. Refract. Surg. 25(8), 687; author reply 687-688 (2009).
Schrier A, Greebel G, Attia H, Trokel S, Smith EF. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J. Refract. Surg. 25(9), S799-S802 (2009).
Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27(5), 590-594 (2008).
Moren H, Malmsjo M, Mortensen J, Ohrstrom A. Riboflavin and ultraviolet A collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29 (1), 102-104 (2010).
Micelli Ferrari T, Leozappa M, Lorusso M, Epifani E, Micelli Ferrari L. Escherichia coli keratitis treated with ultraviolet A/ riboflavin corneal cross-linking: a case report. Eur. J. Ophthalmol. 19(2), 295-297 (2009).
Kanellopoulos AJ, Binder PS. Collagen cross-linking (CCL) with sequential topography-guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty. Cornea 26(7), 891-895 (2007).
Kymionis GD, Kontadakis GA, Kounis GA et al. Simultaneous topography-guided PRK followed by corneal collagen cross-linking for keratoconus. J. Refract. Surg. 25(9), S807-S811 (2009).
Coskunseven E, Jankov MR 2nd, Hafezi F, Atun S, Arslan E, Kymionis GD. Effect of treatment sequence in combined intrastromal corneal rings and corneal collagen crosslinking for keratoconus. J. Cataract Refract. Surg. 35(12), 2084-2091 (2009).
Kamburoglu G, Ertan A. Intacs implantation with sequential collagen cross-linking treatment in postoperative LASIK ectasia. J. Refract. Surg. 24(7), S726-S729 (2008).
Chan CC, Sharma M, Wachler BS. Effect of inferior-segment Intacs with and without C3 -R on keratoconus. J. Cataract Refract. Surg. 33(1), 75-80 (2007).
Wollensak G, Sporl E, Reber F, Pillunat L, Funk R. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res. 35(6), 324-328 (2003).
Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J. Cataract Refract. Surg. 29(9), 1786-1790 (2003).
Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J. Cataract Refract. Surg. 35(8), 1358-1362 (2009).
Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea 28(4), 474-476 (2009).
Rama P, Di Matteo F, Matuska S, Paganoni G, Spinelli A. Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J. Cataract Refract. Surg. 35(4), 788-791 (2009).
Perez-Santonja JJ, Artola A, Javaloy J, Alio JL, Abad JL. Microbial keratitis after corneal collagen crosslinking. J. Cataract Refract. Surg. 35(6), 1138-1140 (2009).
Koch DD, Kohnen T, McDonnell PJ, Menefee RF, Berry MJ. Hyperopia correction by noncontact holmium:YAG laser thermal keratoplasty. United States Phase IIA clinical study with a 1-year follow-up. Ophthalmology 103(10), 1525-1535; discussion 1536 (1996).
Koch DD, Abarca A, Villarreal R et al. Hyperopia correction by noncontact holmium:YAG laser thermal keratoplasty. Clinical study with two-year follow-up. Ophthalmology 103(5), 731-740 (1996).
Alio JL, Ismail MM, Sanchez Pego JL. Correction of hyperopia with non-contact Ho:YAG laser thermal keratoplasty. J. Refract. Surg. 13(1), 17-22 (1997).
Fernandez-Suntay JP, Pineda IR, Azar DT. Conductive keratoplasty. Int. Ophthalmol. Clin. 44(1), 161-168 (2004).
McDonald MB, Davidorf J, Maloney RK, Manche EE, Hersh P. Conductive keratoplasty for the correction of low to moderate hyperopia: 1-year results on the first 54 eyes. Ophthalmology 109(4), 637-649; discussion 649-650 (2002).
McDonald MB, Hersh PS, Manche EE, Maloney RK, Davidorf J, Sabry M. Conductive keratoplasty for the correction of low to moderate hyperopia: U.S. clinical trial 1-year results on 355 eyes. Ophthalmology 109(11), 1978-1989; discussion 1989-1990 (2002).
Holzer MP, Mannsfeld A, Ehmer A, Auffarth GU. Early outcomes of INTRACOR femtosecond laser treatment for presbyopia. J. Refract. Surg. 25(10), 855-861 (2009).
Ruiz LA, Cepeda LM, Fuentes VC. Intrastromal correction of presbyopia using a femtosecond laser system. J. Refract. Surg. 25(10), 847-854 (2009).
Terry MA, Ousley PJ. Deep lamellar endothelial keratoplasty in the first United States patients: early clinical results. Cornea 20(3), 239-243 (2001).
Terry MA, Ousley PJ. Deep lamellar endothelial keratoplasty visual acuity, astigmatism, and endothelial survival in a large prospective series. Ophthalmology 112(9), 1541-1548 (2005).
Terry MA. Deep lamellar endothelial keratoplasty (DLEK): pursuing the ideal goals of endothelial replacement. Eye (Lond.) 17(8), 982-988 (2003).
Terry MA. A new approach for endothelial transplantation: deep lamellar endothelial keratoplasty. Int. Ophthalmol. Clin. 43(3), 183-193 (2003).
Terry MA, Ousley PJ. Replacing the endothelium without corneal surface incisions or sutures: the first United States clinical series using the deep lamellar endothelial keratoplasty procedure. Ophthalmology 110 (4), 755 -764; discussion 764 (2003).
Terry MA. Endothelial replacement: the limbal pocket approach. Ophthalmol. Clin. North Am. 16(1), 103-112 (2003).
John T. Use of indocyanine green in deep lamellar endothelial keratoplasty. J. Cataract Refract. Surg. 29(3), 437-443 (2003).
Amayem AF, Terry MA, Helal MH et al. Deep lamellar endothelial keratoplasty: surgery in complex cases with severe preoperative visual loss. Cornea 24(5), 587-592 (2005).
Fogla R, Padmanabhan P. Initial results of small incision deep lamellar endothelial keratoplasty (DLEK). Am. J. Ophthalmol. 141(2), 346-351 (2006).
Terry MA, Ousley PJ. Rapid visual rehabilitation after endothelial transplants with deep lamellar endothelial keratoplasty (DLEK). Cornea 23(2), 143-153 (2004).
Melles GR, Wijdh RH, Nieuwendaal CP. A technique to excise the Descemet membrane from a recipient cornea (descemetorhexis). Cornea 23(3), 286-288 (2004) .
Price FW Jr, Price MO. Descemet's stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J. Refract. Surg. 21(4), 339-345 (2005) .
Price MO, Price FW Jr. Descemet's stripping with endothelial keratoplasty: comparative outcomes with microkeratome-dissected and manually dissected donor tissue. Ophthalmology 113(11), 1936-1942 (2006).
Price FW Jr, Price MO. Descemet's stripping with endothelial keratoplasty in 200 eyes: early challenges and techniques to enhance donor adherence. J. Cataract Refract. Surg. 32(3), 411-418 (2006).
Melles GR, Eggink FA, Lander F et al. A surgical technique for posterior lamellar keratoplasty. Cornea 17(6), 618-626 (1998).
Bradley JC, McCartney DL. Descemet's stripping automated endothelial keratoplasty in intraoperative floppy-iris syndrome: suture-drag technique. J. Cataract Refract. Surg. 33(7), 1149-1150 (2007) .
Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea 25(8), 886-889 (2006).
Bahar I, Kaiserman I, Levinger E, Sansanayudh W, Slomovic AR, Rootman DS. Retrospective contralateral study comparing Descemet stripping automated endothelial keratoplasty with penetrating keratoplasty. Cornea 28(5), 485-488 (2009).
Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology 115(9), 1525-1533 (2008).
Lee WB, Jacobs DS, Musch DC, Kaufman SC, Reinhart WJ, Shtein RM. Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology 116(9), 1818-1830 (2009).
Bahar I, Kaiserman I, Sansanayudh W, Levinger E, Rootman DS. Busin guide vs forceps for the insertion of the donor lenticule in Descemet stripping automated endothelial keratoplasty. Am. J. Ophthalmol. 147(2), 220-226.e1 (2009).
Busin M, Bhatt PR, Scorcia V. A modified technique for Descemet membrane stripping automated endothelial keratoplasty to minimize endothelial cell loss. Arch. Ophthalmol. 126(8), 1133-1137 (2008).
Suh LH, Yoo SH, Deobhakta A et al. Complications of Descemet's stripping with automated endothelial keratoplasty: survey of 118 eyes at One Institute. Ophthalmology 115(9), 1517-1524 (2008).
Terry MA, Chen ES, Shamie N, Hoar KL, Friend DJ. Endothelial cell loss after Descemet's stripping endothelial keratoplasty in a large prospective series. Ophthalmology 115(3), 488-496.e3 (2008).
Terry MA, Shamie N, Chen ES, Hoar KL, Friend DJ. Endothelial keratoplasty a simplified technique to minimize graft dislocation, iatrogenic graft failure, and pupillary block. Ophthalmology 115(7), 1179-1186 (2008).
Jordan CS, Price MO, Trespalacios R, Price FW Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms. Br. J. Ophthalmol. 93(3), 387-390 (2009).
Koenig SB, Covert DJ, Dupps WJ Jr, Meisler DM. Visual acuity, refractive error, and endothelial cell density six months after Descemet stripping and automated endothelial keratoplasty (DSAEK). Cornea 26(6), 670-674 (2007).
Price MO, Price FW Jr. Endothelial cell loss after Descemet stripping with endothelial keratoplasty influencing factors and 2-year trend. Ophthalmology 115(5), 857-865 (2008).
Covert DJ, Koenig SB. Descemet stripping and automated endothelial keratoplasty (DSAEK) in eyes with failed penetrating keratoplasty. Cornea 26(6), 692-696 (2007).
Chen ES, Shamie N, Terry MA, Hoar KL. Endothelial keratoplasty: improvement of vision after healthy donor tissue exchange. Cornea 27(3), 279-282 (2008).
Chen ES, Terry MA, Shamie N, Hoar KL, Friend DJ. Descemet-stripping automated endothelial keratoplasty: six-month results in a prospective study of 100 eyes. Cornea 27(5), 514-520 (2008).
Mearza AA, Qureshi MA, Rostron CK. Experience and 12-month results of Descemet-stripping endothelial keratoplasty (DSEK) with a small-incision technique. Cornea 26(3), 279-283 (2007).
Terry MA, Shamie N, Chen ES et al. Endothelial keratoplasty for Fuchs' dystrophy with cataract: complications and clinical results with the new triple procedure. Ophthalmology 116(4), 631-639 (2009).
Price MO, Baig KM, Brubaker JW, Price FW Jr. Randomized, prospective comparison of precut vs surgeon-dissected grafts for Descemet stripping automated endothelial keratoplasty. Am. J. Ophthalmol. 146(1), 36-41 (2008).
Terry MA, Shamie N, Chen ES, Phillips PM, Hoar KL, Friend DJ. Precut tissue for Descemet's stripping automated endothelial keratoplasty: vision, astigmatism, and endothelial survival. Ophthalmology 116(2), 248-256 (2009).
Christo CG, van Rooij J, Geerards AJ, Remeijer L, Beekhuis WH. Suture-related complications following keratoplasty: a 5-year retrospective study. Cornea 20(8), 816-819 (2001).
Ingraham HJ, Donnenfeld ED, Perry HD. Massive suprachoroidal hemorrhage in penetrating keratoplasty. Am. J. Ophthalmol. 108(6), 670-675 (1989).
Price FW Jr, Whitson WE, Ahad KA, Tavakkoli H. Suprachoroidal hemorrhage in penetrating keratoplasty. Ophthalmic Surg. 25(8), 521-525 (1994).
Melles GR, Lander F, Rietveld FJ. Transplantation of Descemet's membrane carrying viable endothelium through a small scleral incision. Cornea 21(4), 415-418 (2002).
Melles GR, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea 25(8), 987-990 (2006).
Shimmura S, Miyashita H, Konomi K et al. Transplantation of corneal endothelium with Descemet's membrane using a hyroxyethyl methacrylate polymer as a carrier. Br. J. Ophthalmol. 89(2), 134-137 (2005).
Tappin M. A method for true endothelial cell (Tencell) transplantation using a custom-made cannula for the treatment of endothelial cell failure. Eye (Lond.) 21(6), 775-779 (2007).
Gomaa A, Comyn O, Liu C. Keratoprostheses in clinical practice -a review. Clin. Experiment Ophthalmol. 38(2), 211-224 (2010).
Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Keratoprosthesis: the Dohlman-Doane device. Am. J. Ophthalmol. 140(6), 1032-1038 (2005).
Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 113(10), 1779.e1-e7 (2006).
Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 28(3), 321-327 (2009).
Chew HF, Ayres BD, Hammersmith KM et al. Boston Keratoprosthesis outcomes and complications. Cornea 28(9), 989-996 (2009).
Strampelli B. Keratoprosthesis with osteodontal tissue. Am. J. Ophthalmol. 89, 1029-1039 (1963).
Casey TA. Osteo-odonto-keratoprosthesis. Proc. R. Soc. Med. 59(6), 530-531 (1966).
Temprano J. Keratoprosthesis with tibial autograft. Refract. Corneal Surg. 9, 192-193 (1993).
Fraunfelder FW, Rich LF. Possible adverse effects of drugs used in refractive surgery. J. Cataract Refract. Surg. 29(1), 170-175 (2003).
Liu C, Okera S, Tandon R, Herold J, Hull C, Thorp S. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK. Br. J. Ophthalmol. 92(9), 1211-1217 (2008).
Tan DT, Tay AB, Theng JT et al. Keratoprosthesis surgery for end-stage corneal blindness in asian eyes. Ophthalmology 115(3), 503-510.e3 (2008).
Crawford GJ, Hicks CR, Lou X et al. The Chirila Keratoprosthesis: Phase I human clinical trial. Ophthalmology 109(5), 883-889 (2002).
Chirila TV. An overview of the development of artificial corneas with porous skirts and the use of PHEMA for such an application. Biomaterials 22(24), 3311-3317 (2001).
Hicks CR, Crawford GJ, Tan DT et al. AlphaCor cases: comparative outcomes. Cornea 22(7), 583-590 (2003).
Pintucci S, Pintucci F, Cecconi M, Caiazza S. New Dacron tissue colonisable keratoprosthesis: clinical experience. Br. J. Ophthalmol. 79(9), 825-829 (1995).
Maskati QB, Maskati BT. Asian experience with the Pintucci keratoprosthesis. Indian J. Ophthalmol. 54(2), 89-94 (2006).
Stoiber J, Fernandez V, Lamar PD et al. Biocompatibility of a nonpenetrating synthetic cornea in vascularized rabbit corneas. Cornea 24(4), 467-473 (2005).
Stoiber J, Fernandez V, Kaminski S et al. Biological response to a supraDescemetic synthetic cornea in rabbits. Arch. Ophthalmol. 122(12), 1850-1855 (2004).
Myung D, Farooqui N, Zheng LL et al. Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing. J. Biomed. Mater. Res. A 90(1), 70-81 (2009).
McLaughlin CR, Fagerholm P, Muzakare L et al. Regeneration of corneal cells and nerves in an implanted collagen corneal substitute. Cornea 27(5), 580-589 (2008).
Merrett K, Fagerholm P, McLaughlin CR et al. Tissue-engineered recombinant human collagen-based corneal substitutes for implantation: performance of type I versus type III collagen. Invest. Ophthalmol. Vis. Sci. 49(9), 3887-3894 (2008).
Liu Y, Gan L, Carlsson DJ et al. A simple, cross-linked collagen tissue substitute for corneal implantation. Invest. Ophthalmol. Vis. Sci. 47(5), 1869-1875 (2006).
Griffith M, Jackson WB, Lagali N, Merrett K, Li F, Fagerholm P. Artificial corneas: a regenerative medicine approach. Eye (Lond.) 23(10), 1985-1989 (2009).

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author(s)

Jean Chuo, MD

UBC Department of Ophthalmology & Visual Sciences Eye Care Centre, Vancouver, British Columbia, Canada

Disclosures

Disclosure: Jean Chuo, MD, has disclosed no relevant financial relationships.

Sonia N. Yeung, MD, PhD

UBC Department of Ophthalmology & Visual Sciences Eye Care Centre, Vancouver, British Columbia, Canada

Disclosures

Disclosure: Sonia N. Yeung, MD, PhD, is funded by the Canadian National Institute for the Blind through the EA Baker Scholarship.

Guillermo Rocha, MD, FRCSC

Department of Ophthalmology, University of Manitoba, Winnipeg, Brandon Regional Health Authority, Brandon, MB, Canada

Disclosures

Disclosure: Guillermo Rocha, MD, FRCSC, has disclosed no relevant financial relationships.

Editor(s)

Elisa Manzotti

Editorial Director, Future Science Group, London, United Kingdom

Disclosures

Disclosure: Elisa Manzotti has disclosed no relevant financial relationships.

CME Author(s)

Charles P. Vega, MD

Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine

Disclosures

Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Sarah Fleischman

CME Program Manager, Medscape, LLC

Disclosures

Disclosure: Sarah Fleischman has disclosed no relevant financial relationships.

CME

Modern Corneal and Refractive Procedures

Authors: Jean Chuo, MD; Sonia N. Yeung, MD, PhD; Guillermo Rocha, MD, FRCSC
CME Released: 4/13/2011
THIS ACTIVITY HAS EXPIRED
Valid for credit through: 4/13/2012

Start Activity

Target Audience and Goal Statement

This activity is intended for ophthalmologists and other physicians who perform corneal and refractive surgical procedures.

The goal of this activity is to evaluate modern techniques of corneal and refractive surgical procedures.

Upon completion of this activity, participants will be able to:

Analyze potential benefits of the femtosecond laser in corneal procedures
Evaluate current practices in keratectomy
Distinguish critical elements of corneal collagen crosslinking
Describe the use of the Boston keratoprosthesis

Disclosures

Author(s)

Jean Chuo, MD

UBC Department of Ophthalmology & Visual Sciences Eye Care Centre, Vancouver, British Columbia, Canada

Disclosures

Disclosure: Jean Chuo, MD, has disclosed no relevant financial relationships.

Sonia N. Yeung, MD, PhD

UBC Department of Ophthalmology & Visual Sciences Eye Care Centre, Vancouver, British Columbia, Canada

Disclosures

Disclosure: Sonia N. Yeung, MD, PhD, is funded by the Canadian National Institute for the Blind through the EA Baker Scholarship.

Guillermo Rocha, MD, FRCSC

Department of Ophthalmology, University of Manitoba, Winnipeg, Brandon Regional Health Authority, Brandon, MB, Canada

Disclosures

Disclosure: Guillermo Rocha, MD, FRCSC, has disclosed no relevant financial relationships.

Editor(s)

Elisa Manzotti

Editorial Director, Future Science Group, London, United Kingdom

Disclosures

Disclosure: Elisa Manzotti has disclosed no relevant financial relationships.

CME Author(s)

Charles P. Vega, MD

Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine

Disclosures

Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Sarah Fleischman

CME Program Manager, Medscape, LLC

Disclosures

Disclosure: Sarah Fleischman has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Expert Reviews Ltd. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

processing....

Five-year View

Corneal surgery has evolved exponentially over the past few years. We propose that the evolution of corneal surgical techniques will occur on three fronts: biological, technological and intellectual innovation. As we have discussed in this article, some of the most advanced surgical techniques (e.g., DMEK) are the product of intellectual ingenuity, without the need for expensive equipment. Wavefront technology, on the other hand, has required the perfecting of numerous aspects of technology. We anticipate that, in the future, corneal regeneration at different levels will become routine, with any number of approaches such as bioengineered scaffolds, ex vivo augmentation of stem cells or pharmacologic endothelial cell regeneration. In refractive surgery, we predict that ‘one-step’ lasers will offer what is currently possible with two separate instruments, and that we will continue to see innovations in presbyopic corrections. Finally, there is no limit to what the human mind can devise. Whether by designing innovative surgical approaches, or by developing new technology, we can guarantee that the cornea, merely 0.5 mm in thickness, will continue its journey of being prodded, diagnosed, spliced, regenerated and cured.

« Back

Page 7 of 8

Key Issues

CME Information

References

CME

Modern Corneal and Refractive Procedures

Target Audience and Goal Statement

Disclosures

Author(s)

Jean Chuo, MD

Sonia N. Yeung, MD, PhD

Guillermo Rocha, MD, FRCSC

Editor(s)

Elisa Manzotti

CME Author(s)

Charles P. Vega, MD

CME Reviewer(s)

Nafeez Zawahir, MD

Sarah Fleischman